home *** CD-ROM | disk | FTP | other *** search
/ Clinical Endocrinology / Clinical Endocrinology.iso / mac / 00000000 / 01000000 / 01030000 / 01030603.dir / 00144_Bitmap_Dummy Text (.png) < prev    next >
Bitmap Image  |  1995-11-09  |  12KB  |  287x293  |  1-bit (2 colors)
Labels: text | screenshot | black | black and white | font | document
OCR: , prolacti In all patients treated with bromocriptir ze levels fall to normal. Pituitary tumour s particularly decreases in about fifty per cent of cases, ting those with mixed GH and prolactin-secr tumours in whom, because of this effect irst. bromocriptine should probably be used of the GH Although, in most patients, the respons criptine, level to octreotide is better than to brom who there are occasional acromegalic patient riptine respond better to bromocriptine. Bromo ets include may be administered orally, but side effe ing. These postural hypotension, nausea and vomi se (e.g. may be avoided by starting with a low d owly (i.e. 1.25mg per day), increasing the dosage sl o take the every three days) and advising patients drug during meals. See earlier: riptine . Comparison of Octreotide ...